DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹28,011 Cr | ₹24,670 Cr | ₹21,545 Cr | ₹19,048 Cr | ₹17,517 Cr |
What is the latest Revenue of DR REDDYS LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹28,011 Cr |
| Mar2024 | ₹24,670 Cr |
| Mar2023 | ₹21,545 Cr |
| Mar2022 | ₹19,048 Cr |
| Mar2021 | ₹17,517 Cr |
How is Revenue of DR REDDYS LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹28,011 Cr | 13.54 | |
| Mar2024 | ₹24,670 Cr | 14.50 | |
| Mar2023 | ₹21,545 Cr | 13.11 | |
| Mar2022 | ₹19,048 Cr | 8.74 | |
| Mar2021 | ₹17,517 Cr | - | |
Compare Revenue of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹106,373.9 Cr | 2.7% | 7.1% | 2.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,402.0 Cr | 1.2% | -0.9% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,277.0 Cr | 2.7% | -3.8% | 5.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,140.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹107,398.0 Cr | -0.1% | -8.2% | -8.3% | Stock Analytics | |
| MANKIND PHARMA | ₹85,818.0 Cr | 0.9% | -6.1% | -15.8% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 2.7% |
7.1% |
2.8% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses